Salman Khan NCDRC Stay: A Wake-Up Call on Celebrity-Endorsed Tobacco Surrogac
By Adv. Amarjeet Singh Panghal Founder, PRAN – Policy Research Action Network Foundation Advocate, Supreme Court of India
NCDRC stays coercive action against Salman Khan in the Rajshree case. PRAN Foundation exposes how celebrity-backed surrogate advertising undermines India’s tobacco control and the Consumer Protection Act 2019.
This Is Not Just a Case—It’s a Systemic Failure
The interim relief granted to Salman Khan by the National Consumer Disputes Redressal Commission (NCDRC) is being framed by many as a mere procedural victory.
That framing is dangerously incomplete.
This case exposes a deeper, nationwide ecosystem where celebrity endorsements are used to normalize and indirectly promote tobacco consumption—despite clear legal prohibitions. At stake is the credibility of the Consumer Protection Act, 2019 and India’s entire public health regulatory framework.
The "Dirty Secret" of “Elaichi” Advertising
Let’s call it what it is: “Elaichi ads” are not about cardamom. They are a strategic bypass of the law designed for:
Brand recall for pan masala.
Tobacco adjacency marketing.
Circumventing statutory bans through clever packaging.
Under the CCPA Guidelines, 2022, surrogate advertising is strictly illegal. Brand extensions cannot be used to indirectly promote restricted products. Yet, prime-time media is flooded with this content. This is not just a regulatory oversight; it is a regulatory failure.
Celebrity Endorsements: Influence Without Accountability
Shah Rukh Khan
Ajay Devgn
Akshay Kumar
Tiger Shroff etc.
These icons possess immense youth appeal. Under the CPA 2019, celebrities are legally required to exercise due diligence.
The Legal Question is simple: Can a celebrity reasonably claim ignorance when the entire country knows what these "brands" actually sell?
Procedural Relief ≠ Substantive Innocence
While the NCDRC has stayed coercive steps, it is vital to distinguish between a "pause" and a "pass":
It is not an acquittal.
It is not a validation of the advertisement.
It is a procedural pause based on concerns regarding the service of notice and proportionality of enforcement (like STF involvement).
These procedural points are important for the rule of law, but they do not address the core illegality of the surrogacy itself.
The Real Damage: Public Health vs. Profit
Surrogate advertising normalizes harmful products and creates aspirational appeal for a brand ecosystem inextricably linked to tobacco. When a young viewer sees their idol promoting “elaichi,” they aren’t buying cardamom—they are buying into a gateway for tobacco addiction.
PRAN’s Position: Time for Legal Accountability
At PRAN (Policy Research Action Network) Foundation, our stance is unequivocal:
1. Enforce Celebrity Liability: Endorsers cannot hide behind creative contracts. If due diligence is mandatory, failure must result in penalties.
2. Zero Tolerance for Surrogacy: We don't need more "warnings"; we need outright enforcement of the existing 2022 CCPA Guidelines.
3. Procedural Integrity is Key: Consumer Commissions must act firmly, but they must follow due process so that their orders are not vulnerable to stays in higher commissions.
Final Word: A Defining Moment
India does not suffer from a lack of law; it suffers from selective enforcement. If surrogate advertising continues unchecked, the law becomes symbolic, public health becomes collateral damage, and celebrity influence becomes legally insulated misinformation.
The PRAN Foundation remains committed to ensuring that the law serves the citizen, not the corporation.
Surrogate Advertising, Tobacco Control India, Celebrity Endorsements Law, Consumer Protection Act 2019, NCDRC Case, Salman Khan Case, Misleading Ads, Public Health Law, PRAN Foundation, Amarjeet Singh Panghal
#ConsumerProtection #TobaccoControl #SurrogateAdvertising #SalmanKhan #NCDRC #IndiaLaw #PublicHealth #CelebrityAccountability #PRANFoundation #LegalReform